IgG-Guided Elimination Diet Beneficial for Irritable Bowel Syndrome
THURSDAY, Feb. 20, 2025 -- Patients with irritable bowel syndrome (IBS) on an immunoglobulin (Ig)G-guided elimination diet are more likely to have a 30 percent or greater reduction in abdominal pain intensity (API), according to a study published online Jan. 31 in Gastroenterology.
Prashant Singh, M.B.B.S., from Michigan Medicine in Ann Arbor, and colleagues conducted a randomized, double-blind trial involving patients with IBS from eight centers to examine the efficacy of an elimination diet utilizing a novel IBS-specific IgG assay. A total of 238 patients positive for one or more foods on an 18-food IgG assay and with an average daily API score between 3 and 7.5 on an 11-point scale during a two-week run-in period were randomly assigned to eight weeks of either an experimental antibody-guided diet or sham diet. The modified intention-to-treat analysis included 223 patients.
The researchers found that significantly more patients in the experimental diet group than the sham diet group met the primary outcome of a ≥30 percent decrease in API for two or more of the last four weeks of the treatment period (59.6 versus 42.1 percent). Compared with the sham group, a significantly higher proportion of patients in the experimental group with constipation-predominant IBS (IBS-C) and IBS with mixed bowel habits (IBS-M) met the primary end point (67.1 versus 35.8 percent and 66 versus 29.5 percent, respectively).
"Given our promising results, a larger study, possibly focusing on IBS-C and IBS-M patients, should be considered," the authors write.
Several authors disclosed ties to biotechnology and pharmaceutical companies, including Biomerica, which funded the study.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Mediterranean Diet Tied to Improvement in Psoriasis
FRIDAY, Sept. 26, 2025 -- A 16-week Mediterranean diet intervention significantly improves psoriasis severity in patients with mild-to-moderate disease receiving stable topical...
Guidance Issued on Impact, Management of Potassium, Phosphorus in CKD
THURSDAY, Sept. 25, 2025 -- Guidance is presented for understanding the impact of potassium and phosphorus additives on people with chronic kidney disease (CKD) and managing their...
hsCRP Levels Increased With Intake of High Levels of Ultraprocessed Food
MONDAY, Sept. 15, 2025 -- Consuming high levels of ultraprocessed foods is associated with increased levels of high-sensitivity C-reactive protein (hsCRP), according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.